期刊文献+

人巨细胞病毒编码US28分子可促进CREB相关转录活性 被引量:1

Human cytomegalovirus-encoded US28 stimulates the CREB related transcriptional activity
下载PDF
导出
摘要 目的:构建人巨细胞病毒(HCMV)编码的趋化因子受体类似物US28基因真核表达载体并观察其对通用转录因子磷酸化的环单磷酸腺苷反应元件结合蛋白(p-CREB)的表达量和相关转录活性的影响。方法:从病毒原液中扩增人巨细胞病毒编码US28基因,构建含US28基因真核表达载体,将该载体与CREB转录活性报告基因和恒定表达的内对照质粒组成的双萤光素酶报告基因系统共转染至HEK293细胞中,Western blot法检测CREB活性形式p-CREB的表达量,并分析US28促使的CREB相关的相对转录活性变化。结果:经PCR鉴定及测序结果证实,所构建的重组载体正确。US28可有效促进p-CREB的表达量与其提升转录的功能活性,揭示了US28与CREB相关转录活性增强的密不可分的关系。结论:人巨细胞病毒可利用宿主通用转录因子CREB增强相关基因转录,从而有可能促进病毒的活化进程。 AIM: To observe the effect of the human cytomegalovirus(HCMV)-encoded chemokine receptor homolog US28 on the human transcription factor CREB related transcriptional activity. METHODS: The US28 gene was cloned from DNA of HCMV-infected fibroblast at 72 h post infection. The amplified gene fragment was subsequently cloned into pcDNA3.1 eukaryotic expression vector. The recombinant plasmid was selected and identified by sequence analysis. US28-pcDNA3.1 was added to the DuaI-Luciferase Reporter Assay System. The immunoreactive bands of phospho-CREB(p-CREB) and luminescence values were observed. RESULTS: The constructed recombinant vector was verified by PCR analysis and DNA sequencing. US28 enhanced the transcriptional efficiency of CRE driving gene via p-CREB. CONCLUSION: HCMV could enhance the transcriptional activity of CRE driving gene via p-CREB. CREB might be involved in the very early reprogramming of the host cell during virus activation.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第5期385-388,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 人巨细胞病毒 US28 CREB因子 人巨细胞病毒活化 human cytomegalovirus US28 cAMP response element binding protein human cytomegalovirus activation
  • 相关文献

参考文献1

二级参考文献47

  • 1Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A,Dhillon AP, Fung J, Gouw A, Gustafsson B, Haga H, Harrison D, Hart J, Hubscher S, Jaffe R, Khettry U, Lassman C, Lewin K, Martinez O, Nakazawa Y, Neil D, Pappo O, Parizhskaya M, Randhawa P, Rasoul-Rockenschaub S, Reinholt F, Reynes M, Robert M, Tsamandas A, Wanless I, Wiesner R, Wernerson A, Wrba F, Wyatt J, Yamabe H. Update of the international banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 2000; 31:792-799.
  • 2Jaln D, Robert ME,Navarro V, Friedman AL, Crawford JM. Total fibrous obliteration of main portal vein and portal foam cell venopathy in chronic hepatic allograft rejection. Arch Pathol Lab Med 2004; 128:64-67.
  • 3Wiesner RH, Ludwig J, van Hoek B, Krom RA. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991; 14(4 Pt 1): 721-729.
  • 4Demetris AJ, Markus BH, Esquivel C, Van Thiel DH, Saidman S,Gordon R, Makowka L, Sysyn GD, Starzl TE. Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 1988; 8:939-947.
  • 5Gubernatis G, Kemnitz J, Tusch G, Pichlmayr R. HLA compatibility and different features of liver allograft rejection. Transpl Int 1988; 1:155-160.
  • 6Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D,Demetris AJ, Van Thiel DH, Starzl TE, Duquesnoy RJ. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993;55:1067-1071.
  • 7Bismuth A, Ducot B, Samuel D, Arulnaden JL, Gugenheim J,Debat P, Azoulay D, Farrokhi P, Pillier-Loriette C, Bourdon G.Liver transplantation and the major histocompatibility complex.Rev Fr Transfus Hemobiol 1991; 34:449-457.
  • 8Batts KP, Moore SB, Perkins JD, Wiesner RH, Grambsch PM,Krom RA. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 1988; 45:376-379.
  • 9Devlin JJ, O'Grady JG, Tan KC, Calne RY, Williams R. Ethnic variations in patient and graft survival after liver transplantation.Identification of a new risk factor for chronic allograft rejection.Transplantation 1993; 56:1381-1384.
  • 10Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995; 346:1117-1121.

共引文献7

同被引文献8

  • 1Ranlinsor WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol, 1996 ; 70(12) 8833 - 8849.
  • 2Stanier P,Taylor DL, Kitchen AD, et al. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. Br Med J,1989;299(6704) :897 -898.
  • 3Goodrum F, Jordan CT, Terhune SS, et al. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations Blood,2004 ; 104 (3) :687 - 695.
  • 4Magri G, Muntasell A, Romo N, et al. NKp46 and DNAM-1 NK cell receptors drive the response to human cytomegalovirus infected myeloid dendritic cells over-coming viral immune evasion strategies. Blood,2010 ; 117 (3) : 848 - 856.
  • 5Wu CA, Pareglio SA, Lingenheld EG. Transmission of murine ytomegalovirus in breast milk: a model of natural infection in neonates. J Virol, 2011 ;85(10) :5115 -5124.
  • 6Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem ceils, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood,2008; 112(9) :3543 -3553.
  • 7Mori T,Ando K, Tanaka K, et al. Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Blood, 1997 ;89 (10) : 3565 - 3573.
  • 8Gibbons AE, Price P, Shellam GR. Analysis of hematopoietic stem and progenitor cell population in cytomegalovirus-infected mice. Blood,1995 ;86(2) :473 -481.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部